BBBeata Błażejewska-Hyżorek

Beata Błażejewska-Hyżorek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Beata Błażejewska-Hyżorek has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Is home-based therapy in Fabry disease the answer to compelling patients’ needs during the COVID-19 pandemic? Survey results from the Polish FD Collaborative Group

    by Mariusz Kusztal, Mariusz Kłopotowski, Stanisława Bazan-Socha, Beata Błażejewska-Hyżorek, Krzysztof Pawlaczyk, Andrzej Oko, Magdalena Krajewska, Michał Nowicki

    Fabry disease (FD) is an X-linked disorder related to a deficiency of the lysosomal enzyme alpha-galactosidase A. In Poland, enzyme replacement therapy (ERT) for FD is offered by the National Health Fund only at selected hospital infusion centers. Patients with FB are considered at a high risk of developing complications from COVID-19. Some patients omitted infusions due to fear of infection or outbreaks in hospitals. Lack of alternative infusion sites hampered the situation. To analyze the impact of the SARS-CoV-2 pandemic on FD patients, especially their fears and expectations, the Polish FD Collaborative Group collaborated on a survey project. Between September and November 2020, we distributed a customized survey exploring expectations and fears among FD subjects. Fifty-five individuals (35 receiving ongoing ERT) from different FD centers completed the study. The median age was 40 years [IQR 25; 50], and gender distribution was almost equal (27 F; 28 M). One-fourth of FD patients reported severe disability limiting transportation for infusions that, in the opinion of the other 25% of responders, consumed >4 h. Forty-four (80%) of all would prefer home infusions performed by a nurse (n = 37, 67.3%) or by a trained non-medical person (n = 7, 12.7%), while 8 (14.5%) patients would choose a local hospital. As expected, transportation time (in one direction) was longer in those preferring home infusions (89.4 ±63 vs 36.2 ±67 min; p = 0.02). Also, those with more severe FD manifestation would prefer home infusions to treatment in FD centers (p = 0.03). The vast majority of respondents (n = 46; 83%) would not change their preferences after pandemic termination. To maintain ERT, FD patients prefer home infusions or those given in the nearest hospital, especially during a pandemic.


  • Open Access

    Morphological and ultrastructural changes in Herpes simplex encephalomyelitis: an attempt to determinate the etiological factor

    by Teresa Wierzba-Bobrowicz, Eliza Lewandowska, Paulina Felczak, Tomasz Stępień, Albert Acewicz, Sylwia Tarka, Beata Błażejewska-Hyżorek, Agnieszka Bednarska, Ewa Matyja, Wiesława Grajkowska

    Herpes simplex encephalomyelitis (HSE) is a rare disease with a high mortality rate. Correct diagnosis is established on the basis of the combination of the clinical and investigative features. Unfortunately, precise diagnosis remains difficult due to several clinical similarities and false...